4//SEC Filing
Easom Eric 4
Accession 0000899243-22-035782
CIK 0001880438other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 8:48 PM ET
Size
10.3 KB
Accession
0000899243-22-035782
Insider Transaction Report
Form 4
Easom Eric
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2022-11-10$15.32/sh−4,413$67,628→ 4,930 total - Sale
Common Stock
2022-11-14$15.04/sh−23$346→ 4,907 total
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]Price reported is a weighted-average sales price. The shares were sold at prices ranging from $15.00 to $15.85. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeother
Related Parties
1- filerCIK 0001914503
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 8:48 PM ET
- Size
- 10.3 KB